James C Hamilton Net Worth & Insider Trades

James C Hamilton Arrowhead Pharmaceuticals, Inc

As of January 15, 2021

What is James C Hamilton's Net Worth?

The current estimated net worth of Arrowhead Pharmaceuticals, Inc's James C Hamilton is estimated to be about $9.97M . James C Hamilton owns about 126,250 units of Arrowhead Pharmaceuticals, Inc common stock. Recently at Arrowhead Pharmaceuticals, Inc, James C Hamilton has sold an estimated value of $3.62M worth.

What is James C Hamilton's Past Insider Trading?

James C Hamilton's largest sale order was 38,750 units , worth over $2.81M on January 7, 2021. In total, James C Hamilton has made about 3 transactions recently at Arrowhead Pharmaceuticals, Inc. James C Hamilton usually trades in January, with the busiest year in 2021. The most recent transaction was a sale order of 10,000 units , worth over $812.94K on January 15, 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was James C Hamilton's Salary in 2020?

As an executive member of Arrowhead Pharmaceuticals, Inc, James C Hamilton has a total base salary of $302,404 . James C Hamilton received compensation valued at about $7,918,296 in 2020. The vast majority of their compensation came in the form of stock awards of $7,430,000 , other earnings, plans or compensations of $170,000 , and other compensation of $15,892 .

What is James C Hamilton's' Mailing Address?

  • Mailing address is 177 East Colorado Blvd Suite 700 Pasadena CA 91105 CA

Arrowhead Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Christopher Anzalone 2020 $785,625 - $12,686,000 - $820,000 $2,892 $14,294,517
Christopher Anzalone 2019 $674,375 - - - $1,540,000 $1,889 $2,216,264
Christopher Anzalone 2018 $643,012 - - - $975,000 $1,889 $1,619,901
Kenneth Myszkowski 2020 $463,750 - $5,391,550 - $213,750 $12,802 $6,081,852
Kenneth Myszkowski 2019 $422,500 - $1,055,700 - $251,550 $11,799 $1,741,549
Kenneth Myszkowski 2018 $384,841 - $276,000 - $180,000 $12,177 $853,018
Javier San Martin 2020 $380,769 $100,000 $7,225,500 - $180,000 $12,802 $7,899,071
Javier San Martin 2019 - - - - - - -
Javier San Martin 2018 - - - - - - -
James Hassard 2020 $302,404 - $7,430,000 - $170,000 $15,892 $7,918,296
James Hassard 2019 - - - - - - -
James Hassard 2018 - - - - - - -
Curt Bradshaw 2020 $338,462 - $6,021,250 - - $13,494 $6,373,206
Curt Bradshaw 2019 - - - - - - -
Curt Bradshaw 2018 - - - - - - -
Bruce D. Given 2020 $409,615 - $15,857,500 - - $76,693 $16,343,808
Bruce D. Given 2019 $488,750 - $2,608,200 - $850,000 $11,799 $3,958,759
Bruce D. Given 2018 $450,362 - $644,000 - $445,900 $11,799 $1,552,061
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/879407/000119312521019640/d76219ddef14a.htm

What are Arrowhead Pharmaceuticals, Inc's Past Insider Trades?

Arrowhead Pharmaceuticals, Inc's most recent insider trade came on February 14, 2022 by Chris Anzalone who sold 146,388 units worth $7.6M . In the last 18 years, insiders at Arrowhead Pharmaceuticals, Inc have sold an estimated value of $157.29M and bought an estimated value of $10.25M worth of shares. Insider trading is most common in January, with the busiest year in 2019. The most active traders at the company are Christopher Anzalone, Chief Executive Officer,  Kenneth Myszkowski, Chief Financial Officer,  and Charles McKenney, Director .

ARROWHEAD PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1